TRY IBOTTLE+ RISK-FREE — SAVE $200 FOR A LIMITED TIME

Our Services

Web Design

Your content goes here. Edit or remove this text inline.

Logo Design

Your content goes here. Edit or remove this text inline.

Web Development

Your content goes here. Edit or remove this text inline.

VIEW ALL SERVICES

Shop Our Products

Hoodies

Your content goes here. Edit or remove this text inline.

T-Shirts

Your content goes here. Edit or remove this text inline.

Jeans

Your content goes here. Edit or remove this text inline.

BROWSE ALL OUR PRODUCTS

More of us

Customer Reviews

Your content goes here. Edit or remove this text inline.

Good Stuff We do!

Your content goes here. Edit or remove this text inline.

More From Us...

Your content goes here. Edit or remove this text inline.

EXPLORE CUSTOMERS STORIES

Discussion – 

0

Discussion – 

0

Polymer Dots Compartmentalized in Liposomes as Photocatalyst for In Situ Hydrogen Therapy


Hydrogen Water Studies

ROS-ScavengingNovel Therapy

Polymer Dots Compartmentalized in Liposomes as Photocatalyst for In Situ Hydrogen Therapy

by Fei Wang, Boyu Zhang, Changfeng Wu, Duyang Gao, Hua Zhou, Xuanjun Zhang, Zhen Yuan

Abstract:

Semiconducting polymer dots (Pdots) have recently attracted considerable attention because of their photocatalytic activity as well as tunable optical band gap. In this contribution, we describe the therapeutic application of Pdots through in situ photocatalytic hydrogen generation. A liposome was employed as a nanoreactor to confine the Pdot photocatalyst, reactants, intermediates, and by‐products. Upon photon absorption by the Pdots, the catalytic cycle is initiated and repeated within the aqueous interior, while the H2 product diffuses across the lipid bilayer to counteract reactive oxygen species (ROS) overexpressed in diseased tissues. Ensemble and single‐particle Förster resonance energy transfer microscopy confirmed the proposed nanoreactor model. We demonstrate that a liposomal nanoreactor containing Pdots and a sacrificial electron donor is a potential photocatalytic nanoreactor for in situ hydrogen therapy.

Read more:

https://doi.org/10.1002/anie.201813066

Related Articles:

Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy

The poor penetration of nanocarriers within tumor dense extracellular matrices (ECM) greatly restricts the access of anticancer drugs to the deep tumor cells, resulting in low therapeutic efficacy. Moreover, the high toxicity of the traditional chemotherapeutics inevitably causes undesirable side…

Year Published: 2023Whole BodyCancer

Hydrogen nanobubbles: A novel approach toward radio-sensitization agents

Background: Ocular melanoma is a rare kind of eye malignancy that threatens the patient’s eyesight. Radiotherapy and surgical removal are the most commonly used therapeutic modalities, and nanomedicine has lately entered this field. Brachytherapy using Ruthenium-106 (106 Ru) ophthalmic plaques…

Year Published: 2023EyeCancer

A drug co-delivery platform made of magnesium-based micromotors enhances combination therapy for…

Combination therapy is an emerging strategy to overcome multidrug resistance (MDR) in hepatocellular carcinoma (HCC) chemotherapy treatment. However, the passive diffusion in traditional delivery systems greatly retards the approach and penetration of drugs into hepatocellular carcinoma cells and thus hinders…

Year Published: 2023LiverCancer

NIR-Activatable Heterostructured Nanoadjuvant Cop/Nicop Executing Lactate Metabolism Interventions for Boosted Photocatalytic Hydrogen…

Near-infrared (NIR) laser-induced photoimmunotherapy has aroused great interest due to its intrinsic non-invasiveness and spatiotemporal precision, while immune evasion evoked by lactic acid (LA) accumulation severely limits its clinical outcomes. Although several metabolic interventions have been devoted to ameliorate immunosuppression,…

Year Published: 2023Whole BodyImmune Regulation

Hydrogen-rich water exerts anti-tumor effects comparable to 5-fluorouracil in a colorectal cancer…

Background: Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the world. Tumor removal remains the preferred frontline treatment; however, effective non-surgical interventions remain a high priority. 5-fluorouracil (5-FU) is a widely used chemotherapy agent, and molecular…

Year Published: 2022IntestineCancer

Molecular Hydrogen Inhibits Colorectal Cancer Growth via the AKT/SCD1 Signaling Pathway

Objective: Molecular hydrogen (H2) has been considered a potential therapeutic target in many cancers. Therefore, we sought to assess the potential effect of H2 on colorectal cancer (CRC) in this study. Methods: The effect of H2 on the proliferation and…

Year Published: 2022IntestineCancer

Sam Soliman

Research Scientist at iBottle

0 Comments

Submit a Comment

My cart
Your cart is empty.

Looks like you haven't made a choice yet.